Victoria Cushing earned her Master's degree in biochemistry from the University of Oxford. She is investigating the structure and function of CAK and is currently pursuing high-resolution structures ...

The Magnetic Resonance group develops and tests new probes, instrumentation and techniques to better plan and assess cancer treatment. Our research is principally focused on the further development ...

Despite significant advancements in cancer treatment, immunotherapy has shown limited success in treating prostate cancer due to the unique resistance mechanisms of its tumours. However, researchers ...

We would like to invite you to join us at our Scientific Apprenticeship Conference. This event will be held on 15 th May 2025 at the Wellcome Collection, Euston, London NW1 2BE. The conference has ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous. They have shown exactly how telomeres – the protective ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Mass photometry (MP) is a light scattering based technique that detects individual, unlabelled molecules in dilute solutions. MP can accurately measure molecular masses in the 40 kDa to 5 MDa range ...